These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11300331)

  • 61. Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy.
    Yeh CN; Jung SM; Chen TW; Hwang TL; Jan YY; Chen MF
    Langenbecks Arch Surg; 2010 Mar; 395(3):217-25. PubMed ID: 20012317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy.
    Sulzyc-Bielicka V; Domagala P; Bielicki D; Safranow K; Domagala W
    Cell Oncol (Dordr); 2014 Feb; 37(1):17-28. PubMed ID: 24277474
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
    Karlberg M; Ohrling K; Edler D; Hallström M; Ullén H; Ragnhammar P
    Anticancer Res; 2010 Feb; 30(2):645-51. PubMed ID: 20332484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
    Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
    J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
    [TBL] [Abstract][Full Text] [Related]  

  • 65. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
    Lenz HJ; Danenberg KD; Leichman CG; Florentine B; Johnston PG; Groshen S; Zhou L; Xiong YP; Danenberg PV; Leichman LP
    Clin Cancer Res; 1998 May; 4(5):1227-34. PubMed ID: 9607581
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma.
    Saito H; Tsujitani S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Surgery; 1999 Feb; 125(2):195-201. PubMed ID: 10026754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.
    Cascinu S; Graziano F; Catalano V; Staccioli MP; Barni S; Giordani P; Rossi MC; Baldelli AM; Muretto P; Valenti A; Catalano G
    Clin Exp Metastasis; 2000; 18(8):651-5. PubMed ID: 11827068
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer.
    Tokunaga T; Oshika Y; Abe Y; Ozeki Y; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
    Br J Cancer; 1998 Mar; 77(6):998-1002. PubMed ID: 9528847
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Study of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) Expressions on 5-Fluorouracil in Oral Squamous Cell Carcinoma.
    Akhter K; Enamur Rashid M
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):503-508. PubMed ID: 30803213
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
    Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H
    Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma.
    Maeda K; Nishiguchi Y; Yashiro M; Yamada S; Onoda N; Sawada T; Kang SM; Hirakawa K
    Int J Mol Med; 2000 Apr; 5(4):373-8. PubMed ID: 10719053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.
    Westra JL; Hollema H; Schaapveld M; Platteel I; Oien KA; Keith WN; Mauritz R; Peters GJ; Buys CH; Hofstra RM; Plukker JT
    Ann Oncol; 2005 Oct; 16(10):1646-53. PubMed ID: 16012177
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer.
    Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N
    Anticancer Res; 2011 Sep; 31(9):2763-71. PubMed ID: 21868518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer.
    Imdahl A; Bognar G; Schulte-Mönting J; Schöffel U; Farthmann EH; Ihling C
    Eur J Cardiothorac Surg; 2002 Apr; 21(4):657-63. PubMed ID: 11932164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Hitre E; Budai B; Adleff V; Czeglédi F; Horváth Z; Gyergyay F; Lövey J; Kovács T; Orosz Z; Láng I; Kásler M; Kralovánszky J
    Pharmacogenet Genomics; 2005 Oct; 15(10):723-30. PubMed ID: 16141798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.